| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |